Copyright
©The Author(s) 2024.
World J Cardiol. Apr 26, 2024; 16(4): 186-190
Published online Apr 26, 2024. doi: 10.4330/wjc.v16.i4.186
Published online Apr 26, 2024. doi: 10.4330/wjc.v16.i4.186
Trial name | Design | Interventions arm | Unique identifier | n | Primary endpoint |
LeCaRt trial | RCT | LBBP-CRT vs BiVP-CRT | NCT05365568 | 170 | Composite of death, HF hospitalization or worsening HF |
LEFT-BUNDLE-CRT trial | RCT | LBBP-CRT vs BiVP-CRT | NCT05434962 | 176 | Positive CRT response: improved clinical composite score or > 15% reduction in LVESV |
RAFT-P & A trial | RCT | AV nodal ablation + LBBP-CRT vs AV nodal ablation + BiVP-CRT | NCT05428787 | 284 | Change in NT-ProBNP at 6 months follow-up |
Left vs left trial | RCT | HBP/LBBP-CRT vs BiVP-CRT | NCT05650658 | 2136 | All-cause mortality and HF hospitalization at 5.5 yr |
- Citation: Batta A, Hatwal J. Left bundle branch pacing set to outshine biventricular pacing for cardiac resynchronization therapy? World J Cardiol 2024; 16(4): 186-190
- URL: https://www.wjgnet.com/1949-8462/full/v16/i4/186.htm
- DOI: https://dx.doi.org/10.4330/wjc.v16.i4.186